Article
Reduced myofibroblast transdifferentiation and fibrotic scarring in ischemic stroke after imatinib treatment
2021-10-28
Abstract excerpt
The tyrosine kinase inhibitor imatinib has been reported to improve outcome in patients following ischemic stroke but the exact mechanism remains elusive. Here, utilizing a photothrombotic murine model of middle cerebral artery occlusion (MCAO), we show that imatinib-mediated inhibition of stroke-induced blood-brain barrier (BBB) dysfunction coincided with decreased expression of genes associated with inflammation...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- faaccbba-5b70-501c-9e69-c286d7a4d828
- DOI
- 10.1101/2021.10.28.466225
